MedTrace Logo

The Antibacterial Effect of Nanosilver Fluoride on Primary Teeth

NCT05221749 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-08-18

Study results available
· View outcomes & findings →

Summary

To assess the antibacterial effect of Nanosilver Fluoride (NSF) in relation to caries activity in dentin caries lesions of primary teeth in comparison to Silver Diamine Fluoride (SDF).

Conditions

  • Primary Teeth
  • Microbial Colonization
  • Caries
  • Dental Caries in Children

Interventions

DRUG

Nanosilver Fluoride (NSF)

Optimized synthesis of Nanosilver Fluoride

DRUG

Silver diamine fluoride

Silver Diamine Fluoride

Sponsors & Collaborators

  • Nour Ammar, BDS

    lead OTHER

Principal Investigators

  • Nour Ammar, BDS · Faculty of dentistry, Alexandria University, Alexandria, Egypt.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-15
Primary Completion
2022-04-15
Completion
2022-06-15
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05221749 on ClinicalTrials.gov